Metraipolis › archive › dc_97b034e3dbce

Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers: an update after ISUP/WHO 2022… — Europe PMC PMID:40820938

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40820938
DOI
10.1002/2056-4538.70030
License (as archived)
solo-consultazione
Archived
2026-11-10T04:36:38.592Z
SHA-256 of the archived text
f60f15b805945a8f85e627ccd909e46f331eaad7e03592b64072d41b02b6e2bb
Stable URL of this page
https://metraipolis.com/documento/dc_97b034e3dbce

How to cite

Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers: an update after ISUP/WHO 2022… — Europe PMC PMID:40820938 — Europe PMC (en), https://europepmc.org/article/MED/40820938 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_97b034e3dbce (Metraipolis archive dc_97b034e3dbce, sha256 f60f15b805945a8f85e627ccd909e46f331eaad7e03592b64072d41b02b6e2bb)
BibTeX
@misc{dc97b034e3dbce,
  title = {Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers: an update after ISUP/WHO 2022… — Europe PMC PMID:40820938},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40820938},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_97b034e3dbce; sha256 f60f15b805945a8f85e627ccd909e46f331eaad7e03592b64072d41b02b6e2bb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40820938. Agents can read the archived copy with the MCP tool read_document.